About Author : Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With experience in technical and niche writing, he was encouraged to opt for a career in content writing and now pens down articles pertaining to market research, industry news and business trends.



Contribution by Pankaj Singh

Supemtek® influenza vaccine gains approval in European Union

The European Commission has recently approved the authorization for commercialization of Supemtek®, a quadrivalent recombinant technology-based influenza vaccine, designed for preventing influenza among adults in the age group of 18 years and abo...

Read More
Zymeworks, ALX Oncology to evaluate zanidatamab-ALX148 combination

Zymeworks Inc., a clinical-stage biopharmaceutical company involved in developing multifunctional biotherapeutics has recently entered into a clinical collaboration with ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, to assess ...

Read More
DW Healthcare Partners invests in virtual care provider CareXM

Healthcare focused private equity firm, DW Healthcare Partners, has reportedly shared plans to partner with virtual care and patient engagement solutions provider, CareXM. The deal represents one of the three investments in DW Healthcare Partners&rsq...

Read More
Verano Holdings acquires Alternative Medical and its affiliate firms

Verano Holdings, a renowned owner, operator, as well as manager of cannabis facilities, has reportedly announced that it has inked a new deal to acquire and integrate with Alternative Medical Enterprises, Plants of Ruskin, and other affiliated firms ...

Read More
Oxurion NV Announced the Confirmation of New Patents for THR-687

Oxurion NV, a Belgium-based biopharmaceutical company focusing on developing an advanced treatment to preserve the vision of patients suffering from diabetic macular edema (DME), announced that it is strengthening its intellectual property (IP) portf...

Read More
Alzinova reveals plans to start ALZ-101 study for Alzheimers disease

The development of the novel Alzheimer’s disease treatment options is among the most vital health needs across the world today. In a bid to develop therapeutic vaccine for this disease , Sweden-based Alzinova AB has reportedly announced plans t...

Read More
Luna collaborates with SRHO to improve access to physical therapy

Luna Physical Therapy, the California-based healthcare firm offering on-demand physical therapy, has reportedly formed a strategic partnership with SRHO, The National Association to advance its disruptive model of care. SRHO, the National Associatio...

Read More
Walmart to test four new stores as physical & online shopping centers

Walmart is reportedly testing out four new stores that could serve as both, online fulfillment centers and physical shopping destinations, amid the COVID-19 pandemic for the ‘New Era of Retail’. The retail giant has decided to move most o...

Read More
GOI plans to distribute COVID-19 vaccines to healthcare workers first

The Indian government has reportedly expressed plans for the distribution of COVID-19 vaccine beginning from healthcare workers with other groups to be covered in later stages under the initiative. The campaign is likely to take place for more than a...

Read More
New BRAF inhibiting cancer drug depicts promise in early patient trial

A novel drug against cancers with a transmuted BRAF gene has reportedly shown promise in a preliminary patient trial exhibited at the 32nd EORTC-NCI-AACR (virtual) Symposium on Molecular Targets and Cancer Therapeutics. Results of the first and secon...

Read More
AstraZeneca bags CHMP’s recommendation for Trixeo Aerosphere & Forxiga

  AstraZeneca is likely to get approval from the EU after receiving a recommendation from CHMP AstraZeneca is also cleared to resume its COVID-19 vaccine trial in various countries British pharmaceutical firm, AstraZeneca has recently anno...

Read More
Tata Consumer possibly looking to join hands with CCD’s retail outlets

TCPL (Tata Consumer Products) is apparently on the lookout for signing a partnership deal with Cafe Coffee Day’s retail outlets. The thought possibly takes shape on the back of the fact that the deal may offer synergy to the company with its br...

Read More
NuVera announces positive data from FIH feasibility study at TCT meet

NuVera Medical Inc., a privately held firm focused on developing novel imaging platform for complex cardiovascular procedures, has reportedly presented positive outcomes from its FIH (First-in-human) feasibility study evaluating ‘NuVision&trade...

Read More
Sun Pharma recalls RIOMET ER bottles from the American market

Sun Pharmaceutical Industries Limited (Sun Pharma), an Indian multinational pharmaceutical firm, has reportedly recalled 747 bottles of generic diabetes drugs in the United States due to the probability of the affected lot containing cancer-causing N...

Read More
Flash Express secures $200M in PTT Oil & Business led financing round

Two-year-old logistics startup, Flash Express, has reportedly raised a sum of $200 million in a new financing round. The initiative comes as part of the company’s plans for doubling down on a rapidly growing market augmented by demand amid the ...

Read More
China grants $90 million to Sri Lanka for rural development projects

China has reportedly announced that it was providing USD 90 million grant to Sri Lanka in a bid to advance rural development projects in the nation. This news comes two days after President Gotabaya Rajapaksa requested a visiting Chinese delegation t...

Read More
NCCC begins patient enrollment for anti-VISTA antibody clinical trial

Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) has announced that it will be acting as one of the lead institutions for a novel multi-center clinical study of anti-VISTA antibody. The medical institution is now looking to recruit new patients...

Read More
SINTX Technologies develops new fabric for masks using silicon nitride

SINTX Technologies, a renowned OEM of silicon nitride ceramic for non-medical and medical applications, has reportedly announced that it has made considerable progress towards developing a new “catch and kill” mask using silicon nitride t...

Read More
The Issa Brothers, TDR Capital to take on UK supermarket Asda

TDR Capital LLP, a UK-based private equity firm, and Founders and Co-CEOs of EG Group, Zuber and Mohsin Issa have together agreed to acquire Asda, a Walmart-owned supermarket retailer, for a value of £6.8 billion, on a cash-free and debt-f...

Read More
Aspargo acquires oral spray formulation patent rights from Farmalider

Aspargo Laboratories, a renowned US-based clinical-stage biopharmaceutical company, has reportedly inked a new agreement with Spanish pharmaceutical company, Farmalider, S.A., to acquire exclusive international patent rights to its proprietary orally...

Read More
GENFIT & LabCorp Come Together to Develop a Diagnostic Test for NASH

GENFIT, a biopharmaceutical company committed to improving the lives of patients suffering from liver and metabolic diseases, and LabCorp®, a leading life sciences enterprise focuses on guiding patient care decisions and improving health, have si...

Read More
RADLogics obtains FDA's approval for AI-based chest X-Ray App

RADLogics Inc., a healthcare software company developing AI-powered solutions has reportedly received 510(k) clearance from the US FDA (Food and Drug Administration) for its latest AI-Powered chest X-ray pneumothorax application. This clearance provi...

Read More
CDE of China NMPA clears I-Mab’s application for lemzoparlimab

Clinical stage biopharmaceutical major, I-Mab, has reportedly announced that it has received the clearance of the Center for Drug Evaluation of the China National Medical Products Administration for its IND application for lemzoparlimab. The applicat...

Read More
Aoyuan Healthy to acquire 55% equity interest in Liantianmei

Aoyuan Healthy Life Group Company Ltd., a renowned commercial property operation service and property management service provider based in China, has reportedly announced that Guangdong Xinyuerong Industrial Investment Company Limited, the firm&rsquo...

Read More
Anova Enterprises expands AnovaOS™ to boost clinical development

The U.S-based Anova Enterprises, Inc. (Anova) has reportedly expanded the AnovaOS™ technology platform in order to boost the development of promising novel treatments. The platform brings pharmaceutical companies and research sites together to ...

Read More
Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India

India’s Drugs Controller General (DCGI) has approved Pune-based Serum Institute of India (SII) to restart the clinical trial of the Oxford/AstraZeneca COVID-19 vaccine in India. The DCGI has cancelled its previous order of suspending enrollmen...

Read More
Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results

Everest Medicines announced the top-line results from the Phase 1 clinical trial of Taniborbactam with cefepime for treating infections caused by multi-drug resistant pathogens in China. Everest Medicines is a biopharmaceutical company that develops ...

Read More
EP Global Commerce makes offer to increase stake in Metro Cash & Carry

EP Global Commerce, the acquisition vehicle of Slovak and Czech investors, is reportedly launching a new takeover offer to raise its stake in Metro Cash & Carry, a renowned German wholesaler. The new takeover bid aims to increase the company&rsqu...

Read More
Takeda Pharma announces results from its Phase 3 TOURMALINE-MM2 trial

Takeda Pharmaceutical Company Ltd, a renowned Japanese pharmaceutical company, has reportedly announced the outcome of Phase 3 TOURMALINE-MM2 trial that assesses the combination of ixazomib (NINLARO) and lenalidomide, dexamethasone versus dexamethaso...

Read More
Suda Pharmaceuticals Secures Australian Patent for Anagrelide

The shares for Suda Pharmaceuticals were up by 13% after the company received a patent for Anagrelide from the Australian Patent Office. The patent is named as Prevention and Treatment of Metastatic Disease in Thrombocytotic Cancer Patients and will ...

Read More
Novartis announces outcomes from Phase III IRIDIUM study for asthma

Novartis International AG, one of the leading multinational healthcare firms, has reportedly announced outcomes from the crucial Phase III IRIDIUM study of ‘Enerzair Breezhaler’ at ERS( European Respiration Society) International Congress...

Read More
Novartis announces outcomes from Phase III IRIDIUM study for asthma

Novartis International AG, one of the leading multinational healthcare firms, has reportedly announced outcomes from the crucial Phase III IRIDIUM study of ‘Enerzair Breezhaler’ at ERS( European Respiration Society) International Congress...

Read More
Flipkart Wholesale to Launch Services in Bengaluru, Gurugram and Delhi

Flipkart Wholesale, the B2B unit of the Walmart-owned e-commerce firm has launched operations beginning with a fashion segment that focuses on apparel and footwear, two months after taking over Walmart’s Indian business.  Flipkart Wholesa...

Read More
Vir Biotech and GSK join the race find COVID-19 antibody treatment

As the entire world awaits a COVID-19 vaccine, the next big thing in battling the disease could come from a class of biotech therapies such as antibodies designed precisely to attack this virus. As per the latest news, GlaxoSmithKline Plc. and V...

Read More
Walmart announces the launch of Walmart+ to provide free delivery

The world’s biggest retailer Walmart has reportedly announced the launch of its ‘Walmart+’ membership program to provide free delivery to its customers. The program directly aims at challenging the e-commerce giant, Amazon, and will...

Read More
Innovent unveils phase 1/2 clinical study results of PCSK9 antibody

Innovent Biologics, a renowned biopharmaceutical firm that develops, produces, and commercializes innovative medicines to treat metabolic, oncology, autoimmune as well as other prominent diseases, has reportedly announced that results from its Phase ...

Read More
American Airlines asks Federal help, plans to cut off 19,000 workers

After months of warning about forthcoming layoffs once their pandemic bailout expires, American Airlines Inc., is getting closer to making the job cuts. The airline has warned that it will send 19,000 employees off or furlough involuntarily as of 1 O...

Read More
GeoVax to initiate Phase 1 combination therapy trial with MVA62B

GeoVax Labs, Inc., a U.S-based biotechnology firm that focuses on vaccines and immunotherapies for cancer and other infectious, has recently revealed that it has initiated the Phase 1 clinical trial of combination therapy in HIV-infected ad...

Read More
Trump announces emergency authorization for treating COVID-19 patients

U.S. President Donald Trump has reportedly announced emergency authorization for the use of convalescent plasma in the treatment of COVID-19. While Trump reportedly regarded the move to be a breakthrough, one of his top health officials described it ...

Read More
Pfizer/BioNTech evaluates BNT162b2 for large scale clinical trial

The ongoing coronavirus outbreak has brought about major changes to every aspect of life. In times like these, the need to develop a novel treatment for COVID-19 disease is of paramount importance. In a bid to develop an efficient vaccine, Pfizer Inc...

Read More
Serum Institute of India begins Phase 2/3 trials of COVID-19 vaccine

The pharmaceutical company plans to conduct clinical trials at 17 sites across the country Serum Institute of India (SII), an Indian pharmaceutical company that develops immunobiological drugs and vaccines, has recently began the Phase II/III clini...

Read More
M&S to adopt a leaner business model; shed around 7,000 jobs in the UK

Marks & Spencer (M&S), a renowned British retail company, has recently announced that it is planning to cut 7,000 jobs to mitigate heavy losses incurred due to the COVID-19 crisis. The announcement comes as a big blow for Britain’s alre...

Read More
U.S FDA approves Satralizumab for the treatment of NMOSD patients

Genentech Inc., one of leading biotechnology corporations which became a subsidiary of Roche in 2009, has reportedly announced that the U.S FDA (Food and Drug Administration) has reportedly approved Satralizumab for treating adult patients with anti-...

Read More
Appili gets FDA approval to expand the clinical trial of favipiravir

Biopharmaceutical major, Appili Therapeutics Inc., has reportedly announced that it has received the approval of the U.S. Food and Drug Administration (FDA) over its recently filed investigational new drug application for favipiravir, a broad-spectru...

Read More
Saudi begins Phase III clinical trials of Chinese COVID-19 vaccine

The Ministry of Health, Saudi Arabia, has reportedly announced that it will begin the third phase of clinical trials for a COVID-19 vaccine, as part of its cooperation with China’s CanSino Biologics Inc. The trials will be conducted in differen...

Read More
Amazon cleared by UK regulators to buy 16% stake in Deliveroo

The eCommerce giant Amazon has been granted permission to purchase a minority stake in the U.K-based food delivery start-up Deliveroo. The firm was able to convince regulators that the deal would not be detrimental to competition. In May of last yea...

Read More
Australia retail industry in disarray with major slump in sales

Australia’s retailers are reportedly facing a huge crisis of sorts, with the latest data depicting a massive fall in sales volumes. As the nation’s second-largest state enforces a lockdown to fight the ongoing coronavirus, Australia&rsquo...

Read More
Leedy Dental Reveals Renovations and New Dental Implant Center

The Leedy Dental, the U.S-based comprehensive dental practice with expertise in full mouth rehabilitation and implant dentistry, has reportedly completed renovation work in its practice in Abilene, TX.   Among these changes are a brand new...

Read More
UAE online marketplace Noon to enter the food delivery sector

Noon, an e-commerce platform operating in the Middle East, is reportedly planning to launch a food delivery marketplace with an aim to support the region’s food and beverage businesses during the COVID-19 pandemic. According to reports, the de...

Read More
Ecommerce conglomerate Walmart commences renewed attempts to sell Asda

Globally acclaimed retail giant Walmart had reportedly started commencing discussions to sell its Asda business, earlier this year. Walmart’s desire to divest Asda, its grocery arm in UK, is rather well-known. However, the advent of the COVID-1...

Read More
UK inks deal with Pfizer and BioNTech for potential COVID-19 vaccines

Even though the COVID-19 vaccine hasn’t been launched worldwide, it seems that leading nations are competing over who will have first access once a vaccine is ready. Recently, the government of the UK has reportedly signed an agreement with Pfi...

Read More
JCPenney to axe about 1000 jobs as part of its restructuring bid

J.C. Penney Co., Inc., a renowned American departmental store chain, has reportedly announced plans to align its workforce with the strategy of store optimization and limited store footprint. The company states that around 152 retail shops that would...

Read More
Spotify rolls out service in 13 new European markets including Russia

Audio streaming subscription service Spotify has reportedly announced the launch of its streaming services in 13 new markets spread across Europe including Belarus, Croatia, Kosovo, Albania, Bosnia & Herzegovina, North Macedonia, Serbia, Russia, ...

Read More
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19. According to sources familiar with...

Read More
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start human trials. The Indian drug regu...

Read More
Seattle Genetics reveals positive data from tisotumab vedotin trial

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing tisotumab vedotin for the treatmen...

Read More
Celltrion receives positive opinion for Remsima® SC from CHMP

Celltrion Healthcare, one of the leading biopharmaceutical companies headquartered in Incheon, South Korea, has reportedly announced that CHMP (the Committee Medicinal Products for Human Use) has recommended the company to expand the marketing author...

Read More
2020 On-site introduces new solutions for delayed clinical trials

The COVID-19 pandemic has significantly impacted the existing ecosystem of clinical trials as a whole. Except for COVID-19, most of the on-going or new clinical studies have essentially delayed or stopped in several countries across the world. In a ...

Read More
Emergency use authorization of Hydroxychloroquine revoked by U.S. FDA

The malaria drug Hydroxychloroquine has been in the headline for the past few months. The drug was hailed as the game-changer in the treatment of COVID-19 by U.S. President Donald Trump. However, the U.S.FDA (Food and Drug Administration) has reporte...

Read More
Super Retail raises USD 203 million to strengthen online capabilities

Super Retail Group Limited, the Australian company which owns and operates a portfolio of retail brands across Australia, has reportedly raised USD 203 million to strengthen its online capabilities and accelerate growth after the COVID-19 crisis. So...

Read More
China successfully launches the Haiyang-1D satellite into orbit

Haiyang-1D is the 6th satellite in the Haiyang series for Ocean observation satellites and was developed by the Chinese Academy of Space technology (CAST). This is the first successful launch for China since January. The notification of successful...

Read More
MindMed to treat cluster headaches using LSD, announces phase 2 trials

The LSD based drug will be used to treat chronic cluster headaches occurring on one side of the head or over the eye. These trials will be conducted in collaboration with Liechti Lab, University of Basil. Phase 1 trials for the drug are already un...

Read More
Huawei launches advertising campaign in UK amid security review

Chinese telecom major Huawei Technologies has reportedly announced the launch of internet campaign and a newspaper to mark two decades of its successful business in the United Kingdom. The company has also expressed its commitment to providing the be...

Read More
Greenphire introduces new budget tool to streamline clinical trails

Greenphire Inc, one of the world’s leading companies in financial lifecycle management for clinical trials, has reportedly launched a new budget development solution named EnvisiX to address the budgeting challenges experienced by CROs and glob...

Read More
Gilead’s Remdesivir improves clinical outcomes in COVID-19 patients

The novel coronavirus outbreak, which led to the on-going COVID-19 pandemic, has affected over five million people and taken the lives of over 300 thousand worldwide. But unfortunately, researchers have not been able to find treatment for this highly...

Read More
WHO halts Hydroxychloroquine clinical trial over safety concerns

The malaria drug Hydroxychloroquine has been in the headlines for the past few months. The drug was hailed as the game-changer in the treatment of COVID-19 by the Trump administration. However, the WHO (World Health Organization) has reportedly halte...

Read More
BPCL launches WhatsApp initiative to facilitate domestic gas booking

BPCL has launched a domestic gas booking facility through WhatsApp   “Bharat Gas” cylinders can be booked through a Smartline number provided by the company India’s oil marketing major Bharat Petroleum Corporation Limited...

Read More
Poxel announces preclinical outcomes on PXL770 for NASH Combinations

Poxel SA, the France-based dynamic biopharmaceutical firm developing advanced drugs for metabolic diseases, has reportedly announced the preclinical outcomes for PXL770, the main molecule in its AMPK (adenosine monophosphate-activated protein kinase)...

Read More
EMA accepts marketing authorization application for Roxadustat

Japanese pharmaceutical multinational major Astellas Pharma Inc., has announced that the marketing authorization application for anti-anemic drug Roxadustat has been accepted by the European Medicines Agency. The announcement has reportedly been made...

Read More
J.C Penney announces plans to reopen 153 stores amid a pandemic

While American department store chain J.C. Penney Company, Inc., may have got extra time with Chapter 11 bankruptcy filing, a countdown is still looming on the company’s scheduled exit from bankruptcy in November. J.C. Penney was in headlines ...

Read More
Veeva Systems unveils new app MyVeeva for clinical research sites

Veeva Systems, a renowned leader in cloud-based software for the global life sciences industry, has reportedly unveiled a new application for clinical research sites. With competencies for patient adherence, eSource, eConsent, ePRO, virtual visits as...

Read More
Massachusetts earmarks $56m to tackle food insecurity amid COVID-19

In a bid to propel the food supply chain amid COVID-19 fallout, the Baker-Polito administration has announced that state will be infusing $56m to counter food insecurities concerns in Massachusetts. Gov. Charlie Baker and Lt. Gov. Karyn Polito were ...

Read More
CapStone Holdings confirms acquisition of $50M stake in Curaleaf

CapStone Holdings, an investment and business incubator group, recently announced that it has invested about $50 million for a stake in a provider of medical as well as adult-use cannabis products across the U.S., Curaleaf. For the record, CapStone ...

Read More
University of Alberta’s cancer treatment advances to human trial

The treatment would be tested on stage four cancer patients who have not shown response to currently available treatments. University of Alberta has reportedly taken a pioneering step towards developing a treatment for cancer as it announces commenc...

Read More
UK investing in 3 clinical trials to find a cure against COVID-19

While numerous countries are currently working to find a cure for the COVID-19 outbreak, no drug trial has been able to clinically prove that it can treat the coronavirus yet. To further help this global mission of finding a cure, the UK Government h...

Read More